Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Murielle E. Mauer"'
Autor:
Artuur M. Leeuwenberg, Maarten van Smeden, Johannes A. Langendijk, Arjen van der Schaaf, Murielle E. Mauer, Karel G. M. Moons, Johannes B. Reitsma, Ewoud Schuit
Publikováno v:
Diagnostic and Prognostic Research, Vol 6, Iss 1, Pp 1-13 (2022)
Abstract Background Clinical prediction models are developed widely across medical disciplines. When predictors in such models are highly collinear, unexpected or spurious predictor-outcome associations may occur, thereby potentially reducing face-va
Externí odkaz:
https://doaj.org/article/8373a8545fff42b1babb94e9e3a2b729
Autor:
Elizabeth Catherine Smyth, Maren Kristina Knoedler, Magnus Nilsson, Anna Dorothea Wagner, Markus H. Moehler, Nicole C.T. van Grieken, Anne Giraut, Murielle E. Mauer, Florian Lordick
Publikováno v:
Journal of Clinical Oncology. 38:TPS467-TPS467
TPS467 Background: Gastroesophageal adenocarcinoma patients with metastatic lymph nodes (ypN+) or a microscopically incomplete surgical resection (R1) following neoadjuvant chemotherapy are at high risk of disease recurrence. Current practice is to c
Autor:
Hans Wildiers, Monique Elseviers, Murielle E. Mauer, Jonas de Wolf, Edith Bastiaens, Sigrid Hatse, Marije Hamaker, Frank Buntinx, Jan de Lepeleire, Geert Uytterschaut, Konstantinos Tryfonidis, Maryska Janssen-Heijnen
Publikováno v:
Journal of Clinical Oncology. 35:e13066-e13066
e13066 Background: A large prospective cohort study was designed to describe cancer events, referral patterns, anticancer treatments and outcome in NHR. Methods: The study was set up in 39 nursing homes from the Armonea network in Belgium, covering 4
Autor:
Theo Ruers, Cornelis J. A. Punt, Frits van Coevorden, Jean-Pierre Pierie, Inne Borel Rinkes, Jonathan A. Ledermann, Graeme John Poston, Wolf O. Bechstein, Marie-Ange Lentz, Murielle E. Mauer, Eric Van Cutsem, Manfred P. Lutz, Bernard Nordlinger
Publikováno v:
Journal of Clinical Oncology. 33:3501-3501
3501 Background: This study evaluates the benefit of combining systemic chemotherapy (CT) with local tumor destruction by RFA in patients with unresectable CRC LM up to 9 lesions and without extrahepatic disease. Overall survival (OS) at 30 months an
Autor:
Schmoll HJ; Hans-Joachim Schmoll, MD, Martin Luther University, Halle, Germany; Murielle E. Mauer, PhD, and Sandrine Marreaud, PhD, EORTC Headquarters, Brussels, Belgium; and Alexander Stein, MD, Hematology-Oncolology Practice Eppendorf, University Cancer Center Hamburg, Hamburg, Germany., Mauer ME; Hans-Joachim Schmoll, MD, Martin Luther University, Halle, Germany; Murielle E. Mauer, PhD, and Sandrine Marreaud, PhD, EORTC Headquarters, Brussels, Belgium; and Alexander Stein, MD, Hematology-Oncolology Practice Eppendorf, University Cancer Center Hamburg, Hamburg, Germany., Marreaud S; Hans-Joachim Schmoll, MD, Martin Luther University, Halle, Germany; Murielle E. Mauer, PhD, and Sandrine Marreaud, PhD, EORTC Headquarters, Brussels, Belgium; and Alexander Stein, MD, Hematology-Oncolology Practice Eppendorf, University Cancer Center Hamburg, Hamburg, Germany., Stein A; Hans-Joachim Schmoll, MD, Martin Luther University, Halle, Germany; Murielle E. Mauer, PhD, and Sandrine Marreaud, PhD, EORTC Headquarters, Brussels, Belgium; and Alexander Stein, MD, Hematology-Oncolology Practice Eppendorf, University Cancer Center Hamburg, Hamburg, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Apr 10; Vol. 39 (11), pp. 1306-1308. Date of Electronic Publication: 2021 Feb 23.